Novartis Goes Big On Gene Therapy With $8.7bn AveXis Acquisition

 
• By Kevin Grogan
  
Genetics
Novartis aims to be at the forefront of gene therapy • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business